Are you wondering if Botox is owned by Allergan? The answer is yes. Allergan, the manufacturer of Botox and the successful Restatis eye treatment, is a leading pharmaceutical company that develops and manufactures innovative medicines. Botox is an injection of a purified form of botulinum toxin that paralyzes muscles, smooths expression lines and wrinkles on the forehead and around the eyes. It is one of Allergan's most successful assets and is used as a cosmetic treatment.
Patients must pay for Botox out of pocket, as it is not covered by health insurers or government health agencies. In addition to Botox, Allergan manufactures several other pharmaceuticals, including Juvederm (Injectable Filler), CoolSculpting (Cryolipolysis), Alphagan (Brimonidine), Vraylar (Cariprazine HCI), Linzess (linaclotide) and Ubrelvy (ubrogepant). It is important to tell your doctor if you have any medical conditions, such as recent surgery, a pre-existing hernia, and any known sensitivities or allergies before using any of these products. Although Allergan is still an industry leader, it has faced some challenges in recent years.
In 2017, billionaire investor Leon Cooperman suggested on CNBC that Botox maker Allergan could acquire AbbVie. However, this did not come to fruition. Rare side effects of Botox include a visible enlargement in the treated area that may develop two to five months after treatment. This will not resolve on its own and may require surgical intervention for correction.
In conclusion, Allergan is the manufacturer of Botox and the successful Restatis eye treatment. It develops and manufactures several other pharmaceuticals as well. Rare side effects may occur and require surgical intervention for correction.
